Theranexus

ALTHX | PA

Overview

Corporate Details

ISIN(s):: FR0013286259
LEI:: 969500BFCV6IC7MFQP20
Country:: France
Address:: 60 AVENUE ROCKEFELLER, 69008 LYON
Website:: https://www.theranexus.com/en/
Sector:: Professional, scientific and technical activities
Industry:: Research and experimental development on natural sciences and engineering

Description

Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

Chat, Summarize & Extract with AI!

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-05-13 18:00	Regulatory News Service THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-W…	English	391.8 KB
2025-05-13 18:00	Business and Financial Review THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE R…	French	352.9 KB
2025-04-29 19:05	Registration Form URD 2024	French	10.6 MB
2025-04-29 19:00	Earnings Release THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT A…	English	336.5 KB
2025-04-29 19:00	Earnings Release THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS E…	French	297.3 KB
2025-03-06 18:00	Regulatory News Service MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC	French	272.5 KB
2025-01-23 18:15	Report Publication Announcement THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025	English	262.8 KB
2025-01-23 18:00	Report Publication Announcement THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025	French	254.5 KB
2025-01-16 18:00	Declaration of Voting Results & Voting Rights Announcements Information mensuelle relative au nombre total de droits de vote et d'actions c…	French	168.8 KB
2025-01-09 18:00	Report Publication Announcement THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS	English	179.9 KB
2025-01-09 18:00	Report Publication Announcement THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES	French	181.7 KB
2024-12-17 18:15	Capital/Financing Update THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON	English	212.3 KB
2024-12-17 18:15	Capital/Financing Update THERANEXUS FAIT UN POINT SUR SA POSITION DE TRÉSORERIE ET SON HORIZON DE FINANC…	French	230.9 KB
2024-12-17 18:00	M&A Activity THERANEXUS ET EXELTIS (INSUD PHARMA) ANNONCENT UN ACCORD DE LICENCE POUR LA COM…	French	178.0 KB
2024-12-17 18:00	M&A Activity THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIA…	English	177.4 KB